Home Tags Cardiovascular Diseases
Cardiovascular Diseases Related Content
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.
Simone Biscaglia, European Society of Cardiology Member, states the case here for what could be the next (cheap) medical revolution, “reasonable” physical activity for all.
Prof Filippo Graziani, President of the European Federation of Periodontology (EFP), turns the spotlight on periodontitis and answers if gum disease increases the risk of hypertension, heart attack and stroke.
Drs Yuping Wang and David F. Lewis from Louisiana State University Health Sciences Center – Shreveport, discuss the impact of vitamin D deficiency and aberrant vitamin D receptor expression on endothelial function in preeclampsia.
Researchers have found that placenta changes could suggest that male offspring are more at risk of heart problems later on in life.
For a long time the causes of acute coronary syndromes were poorly understood, and, only after the publication of our paper on New England Journal of Medicine on the importance of inflammation it was recognised as a crucial pathogenetic mechanism.
Dr Tejas Patel, a world-renowned interventional cardiologist and endovascular therapist, highlights cardiovascular disease, a leading cause of disability and premature death around the world.
The excellent work of Policlinico Universitario A Gemelli is explored here when it comes to vital research in the field of cardiovascular sciences.
Professor Shuenn-Yuh Lee, National Cheng Kung University, discusses his mission to build a user-friendly development platform with smart wearable technology, in this report.
Transcending morphology, magnetic resonance techniques can be utilised to shed light on processes on the molecular level to unveil pathological alterations preceding anatomical and functional manifestations of (cardiovascular) diseases, in the view of Ulrich Flögel from Heinrich Heine University Düsseldorf, Germany.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explores the emerging role of tumour necrosis factor receptor-associated factor 6 including the challenges and opportunities in this vein.
Thomas Münzel MD, Andreas Daiber PhD, Ulrich Pöschl PhD and Jos Lelieveld PhD discuss the link between air pollution and cardiovascular disease in Europe.
Cardiovascular diseases are on the rise, but so is confusion as to how to prevent them. Shaun Ingram, MD of Cardiac Science takes a look at the data, shares his views and strikes a cautious note of optimism.
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
In this interview, Chair of the ESC Digital Health Committee, Professor Martin Cowie, details the opportunities and challenges in the digital health era when it comes to the field of cardiovascular disease.
Cardiovascular magnetic resonance techniques can unveil metabolic alterations preceding anatomical and functional manifestations of diseases, the Department of Experimental Cardiovascular Imaging explains here.
Diseases could be detected even before people experience symptoms, thanks to a pioneering new health-data programme as part of the government’s modern Industrial Strategy.
Jeremy Hunt commits £70 million funding over three and a half years for the Better Health Programme, a range of health initiatives that could improve the lives of up to 150 million people across 8 emerging economies.
The University of Manchester found that patients with common lung diseases are substantially more likely to suffer a heart attack and develop other major heart problems.
Dr. Connolly, Consultant Interventional Cardiology, talks exclusively to Open Access Government about the NHS use of AI technology like Heartflow in the fight against coronary heart disease.